The renin angiotensin system is implicated in the progression of
atherosclerotic disease as well as of left ventricular dysfunction.
Angiotensin converting enzyme inhibitors and AT1 receptor
antagonists have been proven to reduce morbidity and mortality in
patients with left ventricular dysfunction or in those at high
cardiovascular risk with preserved ventricular function. This book
is intended to summarize evidences and provide a rationale for the
appropriate use of RAS antagonists in cardiovascular diseases. It
will be presented as highly practical information on this topic,
written in a quick-access, no-nonsense format. The emphasis will be
on a just-the-facts clinical approach, heavy on tabular material,
light on dense prose. The involvement of the ISCP will ensure that
the best quality contributors will be involved and establish a
consistent approach to each topic in the series and this title is
no exception. It will contain practical illustrations and is
designed to improve understand and practical usage of
cardiovascular drugs in specific clinical areas.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!